Proteomic Analysis of Uterine Tissues During Peri-Implantation Period in Mice with Experimentally Induced Adenomyosis that Treated with anti-Ngf: Implications for Cell-Cell Adhesion and Metabolic Processes
Open Access
- 16 July 2020
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 28 (1) , 207-217
Abstract
Nerve growth factor (NGF) has been verified to be expressed with higher level in adenomyosis uteri, and its neutralizing antibody has a strong inhibitory influence on inflammation. The present study aimed to explore the effect of anti-NGF on the expression of proteins in uteri of mice-induced adenomyosis and assessed its potential role in improving pregnancy rate. In this study, we established a mouse model of adenomyosis and administrated NGF-neutralizing antibody into mice. The mass spectrometry (MS) analysis of the uteri during the implantation window was performed to explore the essential proteins participating in therapy. Besides, embryos of healthy mice were transferred into the uteri to assess the implantation rate. The results of MS analysis demonstrated that 119 proteins were changed in the adenomyosis group compared with control group, and 126 proteins were differentially expressed in the anti-NGF group compared with the adenomyosis group (fold change > 1.5, P < 0.05. After performing cluster analysis using Mfuzz package, we found that a group of proteins participated in cell-cell adhesion and metabolic processes, which were attenuated in the adenomyosis group, while those were successfully recovered by anti-NGF treatment. Western blotting confirmed that the expression levels of integrin alpha-1 (ITGA1), integrin beta-1 (ITGB1), laminin subunit gamma-1 (LAMC1), and creatine kinase M-type (CKM) were decreased in adenomyosis group, whereas those levels were elevated after anti-NGF treatment. Embryo implantation rate in the adenomyosis group was significantly decreased compared with that in the control group (2.31% vs. 26.15%, P < 0.001) and anti-NGF treatment slightly enhanced the embryo implantation rate in mice with experimentally induced adenomyosis (9.23% vs. 2.31%, P = 0.017). Our results revealed that anti-NGF therapy can improve fertility of mice with experimentally induced adenomyosis, possibly through promoting integrin-related proteins.Keywords
Funding Information
- National Natural Science Foundation of China (81501320)
This publication has 45 references indexed in Scilit:
- steve bAccumulation of nerve growth factor and its receptors in the uterus and dorsal root ganglia in a mouse model of adenomyosisReproductive Biology and Endocrinology, 2011
- Osteopontin and αvβ3 integrin as markers of endometrial receptivity: the effect of different hormone therapiesReproductive BioMedicine Online, 2010
- Tubulointerstitial Nephritis Antigen-Like 1 Is Expressed in the Uterus and Binds with Integrins in Decidualized Endometrium During Postimplantation in Mice1Biology of Reproduction, 2010
- Experimental adenomyosisBest Practice & Research Clinical Obstetrics & Gynaecology, 2006
- Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitizationPain, 2005
- PI3K/Akt and apoptosis: size mattersOncogene, 2003
- High Frequency of Adenomyosis in Postmenopausal Breast Cancer Patients Treated with TamoxifenGynecologic and Obstetric Investigation, 1997
- Adenomyosis in Postmenopausal Breast Cancer Patients Treated with Tamoxifen: A New Entity?Gynecologic Oncology, 1995
- Tamoxifen induced adenomyosis and adenomyomatous endometrial polypBJOG: An International Journal of Obstetrics & Gynaecology, 1993
- Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle.Journal of Clinical Investigation, 1992